EVLO

Evelo Biosciences, Inc. Common Stock

Delisted

EVLO was delisted on the 11th of December, 2023.

66 hedge funds and large institutions have $290M invested in Evelo Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.54M
Puts
$417K
Net Calls
Net Calls Change

Top Buyers

1 +$1.62M
2 +$1.55M
3 +$767K
4
Millennium Management
Millennium Management
New York
+$543K
5
Belvedere Trading
Belvedere Trading
Illinois
+$507K

Top Sellers

1 -$510K
2 -$273K
3 -$222K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$183K
5
Morgan Stanley
Morgan Stanley
New York
-$180K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$224K
27
$216K
28
$208K
29
$194K
30
$158K
31
$149K
32
$145K
33
$135K
34
$122K
35
$119K
36
$108K
37
$99K
38
$99K
39
$98K
40
$96K
41
$86K
42
$86K
43
$84K
44
$81K
45
$76K
46
$76K
47
$73K
48
$69K
49
$62K
50
$61K